Associations of body roundness index with cardiovascular and all-cause mortality: NHANES 2001-2018

Lin Tao1, Liu Miao1, Yu-Jie Guo1

  • 1Departments of Cardiology, Liuzhou People's Hospital, 8 Wenchang Road, Liuzhou, 545006, Guangxi, People's Republic of China.

PubMed

Insights

Body roundness index (BRI) is linked to higher cardiovascular disease (CVD) and all-cause mortality in hypertensive patients. Elevated BRI levels (>5.9 for CVD, >6.3 for all-cause) indicate increased risk, suggesting potential intervention targets.

Area of Science:

  • Cardiology
  • Public Health
  • Biostatistics

Background:

  • Body roundness index (BRI) is an emerging anthropometric indicator associated with cardiovascular diseases.
  • The relationship between BRI and mortality outcomes in hypertensive individuals remains under-investigated.

Purpose of the Study:

  • To investigate the association between BRI and cardiovascular disease (CVD) mortality.
  • To evaluate the association between BRI and all-cause mortality in patients with hypertension.

Main Methods:

  • A prospective cohort study utilizing data from the National Health and Nutrition Examination Survey (NHANES) (2001-2018).
  • Included 15,570 hypertensive patients with a median follow-up of 8.0 years.
  • Weighted restricted cubic spline regression and Cox proportional hazards models were employed.

Main Results:

  • A nonlinear association was observed between BRI and both CVD mortality (P < 0.001) and all-cause mortality (P < 0.001).
  • High BRI levels (>5.9) were associated with increased CVD mortality (HR 1.11, P < 0.001).
  • High BRI levels (>6.3) were associated with increased all-cause mortality (HR 1.09, P < 0.001).

Conclusions:

  • BRI demonstrates a nonlinear association with CVD and all-cause mortality in hypertensive patients.
  • Specific BRI thresholds (5.9 for CVD, 6.3 for all-cause) may serve as targets for interventions to reduce premature death risk.
  • Further validation in large clinical trials is warranted.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
110
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
185
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
360
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
523
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
31